Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases

Pathologie Biologie

Volumn 62, Issue 3, 2014, Pages 152-155

  Pang, F ^a   Jia, X Q ^a   Wang, B ^a   Li, Y H ^a   Zhao, Q G ^a  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

Enterobacteriaceae; IMP carbapenemase; Infection; Orthopedic

Indexed keywords

CARBAPENEMASE; ERTAPENEM; IMIPENEM; IMP 4 CARBAPENEMASE; IMP 8 CARBAPENEMASE; LEVOFLOXACIN; LOMEFLOXACIN; MEROPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; IMP-4 BETA-LACTAMASE, ENTEROBACTER CLOACAE; IMP-4 BETA-LACTAMASE, KLEBSIELLA OXYTOCA; IMP-8 ENZYME; QUINOLONE DERIVATIVE; THIENAMYCIN DERIVATIVE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CASE REPORT; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYME ISOLATION; EPIDEMIC; FEMALE; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INVASIVE PROCEDURE; KLEBSIELLA OXYTOCA; MALE; MIDDLE AGED; NONHUMAN; ORTHOPEDIC INFECTION; ORTHOPEDICS; PLATE FIXATION; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TIBIA FRACTURE; YOUNG ADULT; ARTHRITIS, INFECTIOUS; CHINA; CROSS INFECTION; DISEASE OUTBREAKS; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MICROBIOLOGY; MULTIDRUG RESISTANCE; OSTEITIS; OSTEOSYNTHESIS; PATIENT CARE; PROCEDURES; PROTECTIVE CLOTHING; SURGICAL WOUND INFECTION; WOUND INFECTION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHINA; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FLUOROQUINOLONES; FRACTURE FIXATION, INTERNAL; HUMANS; INFECTION CONTROL; KLEBSIELLA INFECTIONS; KLEBSIELLA OXYTOCA; LEVOFLOXACIN; MALE; MIDDLE AGED; OSTEITIS; PATIENT ISOLATION; PROTECTIVE CLOTHING; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; THIENAMYCINS; UNIVERSAL PRECAUTIONS; WOUND INFECTION;

EID: 84902544120     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2014.01.004     Document Type: Article

References (11)

1. Sheng W.H., Badal R.E., Hsueh P.R. Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2013, 57:2981-2988. SMART Program.
2. Hamada Y., Watanabe K., Tada T., Mezaki K., Takeuchi S., Shimizu T., et al. Three cases of IMP-type metallo-β-lactamase-producing Enterobacter cloacae bloodstream infection in Japan. J Infect Chemother 2013, 19:956-958.
3. Dai W., Sun S., Yang P., Huang S., Zhang X., Zhang L. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing. Infect Genet Evol 2013, 14:1-7.
4. Li H., Zhang J., Liu Y., Zheng R., Chen H., Wang X., et al. Molecular characteristics of carbapenemase-producing Enterobacteriaceae in China from 2008 to 2011: predominance of KPC-2 enzyme. Diagn Microbiol Infect Dis 2014, 78:63-65.
5. CLSI Performance standards for antimicrobial susceptibility testing: 22th informational supplement. CLSI document M100-S22 2012, Clinical and Laboratory Standards Institute, Wayne, Pa.
6. Marchaim D., Navon-Venezia S., Schwaber M.J., Carmeli Y. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 2008, 52:1413-1418.
7. Yan J.J., Hsueh P.R., Ko W.C., Luh K.T., Tsai S.H., Wu H.M., et al. Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001, 45:2224-2228.
8. Poirel L., Héritier C., Tolün V., Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004, 48:15-22.
9. Nordmann P., Poirel L., Carrër A., Toleman M.A., Walsh T.R. How to detect NDM-1 producers. J Clin Microbiol 2011, 49:718-721.
10. Huang S., Dai W., Sun S., Zhang X., Zhang L. Prevalence of plasmid-mediated quinolone resistance and aminoglycoside resistance determinants among carbapeneme non-susceptible Enterobacter cloacae. PLoS One 2012, 7:e47636.
11. Koyano S., Saito R., Nagai R., Tatsuno K., Okugawa S., Okamura N., et al. Molecular characterization of carbapenemase-producing clinical isolates of Enterobacteriaceae in a teaching hospital, Japan. J Med Microbiol 2013, 62:446-450.